Inloggad som:

KIADIS

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

KIADIS
A Phase 3, multicentre, randomised controlled study to compare safety and efficacy of a haploidentical HSCT and adjunctive treatment with ATIR101, a T-lymphocyte enriched leukocyte preparation depleted ex vivo of host alloreactive T- cells, versus a haploidentical HSCT with
A Phase 3, multicentre, randomised controlled study to compare safety and efficacy of a haploidentical HSCT and adjunctive treatment with ATIR101, a T-lymphocyte enriched leukocyte preparation depleted ex vivo of host alloreactive T- cells, versus a haploidentical HSCT with
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 3
Palliativ
Företag

Studien ändrades senast av: studyjohanna (2019-11-06)

Tillbaka till listan